INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-1197955157-finances-money-financial-valuation]( "Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study")
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 StudyExplore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
![Can AI Actually Help Sites]( "Can AI Actually Help Sites?")
Can AI Actually Help Sites?See how AI handles real site documents in real time and walk away with a practical, honest look at what modern data capture could mean for your trial operations.
-
![logistics-discovery-transport-travel-GettyImages-1287428874]( "European Clinical Trial Support Has To Work Country By Country")
European Clinical Trial Support Has To Work Country By CountryCross-border trial access looks easy in policy, but patients face real barriers: travel, documents, reimbursement, language. Plan the support model before recruitment begins so eligible patients can actually participate
-
![data analytics team meeting-GettyImages-2166193783]( "The Ten Commandments Of Vendor Selection")
The Ten Commandments Of Vendor SelectionSelecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
-
Convenient And Comprehensive Care: Best Practices For Pediatric Clinical Trials1/22/2025
Explore the role of Mobile Vision Clinics (MVCs) in enhancing pediatric clinical trials and address the critical need for safety and comfort in pediatric research.
-
Five Questions Every Sponsor Must Ask Before Selecting An eTMF Platform3/12/2026
Lean teams need a strategic eTMF choice. The right platform speeds startup, cuts manual oversight, strengthens site collaboration, and keeps studies inspection‑ready as portfolios grow.
-
Expedite Drug Development With An Integrated CDMO-CRO Model2/6/2026
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
Reframing Vendor Selection: Beyond Price And Past Relationships10/21/2025
An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-2152658176 oncology, doctor, patient]( "Oncology CRO Helping To Bring Cancer Therapies To Patients")
Niche CRO with a difference
Worldwide Clinical Trials Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
-
![Getty Images 1197622090 call center]( "Patient Liaison And Navigator Services For Clinical Trials")
People-focused, detail-driven (and award-winning!) support for participants, sites, and sponsors.
Scout’s patient concierge team manages payments, travel, and scheduling with precision and empathy—helping sites save time, build trust, and reduce dropouts.
-
![GettyImages-887882750 global consulting]( "Portfolio Optimization Strategic Consulting")
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
![Brain-Power-GettyImages-1130826731]( "Comprehensive Services CNS Drug Development")
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
![GettyImages-2161372277 clinical]( "Quality Assurance Services")
The quality assurance (QA) team ensures the highest standards from pre-clinical to market by focusing on operational quality control, quickly identifying potential issues, and implementing necessary changes.
